These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38923563)

  • 1. Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV-co-infected patients with HBsAg loss.
    Gu F; Zeng K; Lan X; He Y; Li F; Tang X; Hu F; Li L
    J Med Virol; 2024 Jun; 96(6):e29762. PubMed ID: 38923563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and factors associated with serum HBV pregenomic RNA levels in Chinese chronic hepatitis B patients.
    Wang ML; Liao J; Ye F; Tao YC; Wu DB; He M; Tang H; Chen EQ
    J Med Virol; 2021 Jun; 93(6):3688-3696. PubMed ID: 32949174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection.
    Larsson SB; Malmström S; Hannoun C; Norkrans G; Lindh M
    Virol J; 2015 Dec; 12():213. PubMed ID: 26645241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes.
    Lin N; Ye A; Lin J; Liu C; Huang J; Fu Y; Wu S; Xu S; Wang L; Ou Q
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31723011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients.
    Jiang B; Su R; Ren D; Zheng X; Cao Y; Mi Y; Wang F; Ma P
    Virus Res; 2020 Dec; 290():198117. PubMed ID: 32800804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive Value of Baseline Serum Marker Levels for the Effect of Interferon Therapy in Patients With Chronic Hepatitis B].
    Yan Y; Davgadorj C; Lyu C; Lu Z; Yu P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):383-390. PubMed ID: 38645851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
    Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
    J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Anderson M; Gersch J; Holzmayer V; Elsner C; Krawczyk A; Kuhns MC; Cloherty G; Dittmer U; Vaillant A
    Hepatol Commun; 2021 Feb; 5(2):189-202. PubMed ID: 33553968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy.
    Hawkins C; Kang M; Bhattacharya D; Cloherty G; Kuhns M; Matining R; Thio C; Samaneka W; Chinula L; Mulinda N; Badal-Faesen S; Sugandhavesa P; Lama J; Gaseitsiwe S; Holzmayer V; Anderson M; Murphy R; Peters M
    AIDS; 2022 Jun; 36(7):975-984. PubMed ID: 35165216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China.
    He Y; Lin W; Li H; Gu F; Zhong H; Lan Y; Li Y; Guo P; Hu F; Cai W; Tang X; Li L
    Chin Med J (Engl); 2023 Nov; 136(22):2686-2693. PubMed ID: 37881959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?
    Audsley J; Avihingsanon A; Littlejohn M; Bowden S; Matthews GV; Fairley CK; Lewin SR; Sasadeusz J
    J Acquir Immune Defic Syndr; 2020 Aug; 84(5):527-533. PubMed ID: 32692112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.
    Freitas N; Lukash T; Gunewardena S; Chappell B; Slagle BL; Gudima SO
    J Virol; 2018 May; 92(10):. PubMed ID: 29491161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
    Huang H; Wang J; Li W; Chen R; Chen X; Zhang F; Xu D; Lu F
    J Clin Virol; 2018; 99-100():71-78. PubMed ID: 29353073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre- and posttreatment: a multicentre observational cohort study.
    Xu L; Li X; Lu L; Liu X; Song X; Li Y; Han Y; Zhu T; Cao W; Li T
    J Viral Hepat; 2022 Aug; 29(8):616-626. PubMed ID: 35582838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Immune Reconstitution-Induced Hepatic Flare on Hepatitis B Surface Antigen Loss in Hepatitis B Virus/Human Immunodeficiency Virus-1 Coinfected Patients.
    Yoshikawa S; Yoshio S; Yoshida Y; Tsutsui Y; Kawai H; Yamazoe T; Mori T; Osawa Y; Sugiyama M; Iwamoto M; Watashi K; Kawaguchi T; Akita T; Tanaka J; Kikuchi Y; Mizokami M; Oka S; Kanto T; Gatanaga H
    J Infect Dis; 2021 Jun; 223(12):2080-2089. PubMed ID: 33073291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact.
    Malmström S; Larsson SB; Hannoun C; Lindh M
    PLoS One; 2012; 7(7):e36349. PubMed ID: 22911677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.
    Madejón A; Romero M; Hernández Á; García-Sánchez A; Sánchez-Carrillo M; Olveira A; García-Samaniego J
    World J Gastroenterol; 2016 Mar; 22(11):3165-74. PubMed ID: 27003993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients.
    Arendt E; Jaroszewicz J; Rockstroh J; Meyer-Olson D; Zacher BJ; Mederacke I; Manns MP; Wedemeyer H; Cornberg M; Wursthorn K
    Viral Immunol; 2012 Dec; 25(6):442-7. PubMed ID: 23131018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term observation on hepatitis B surface antigen seroclearance in therapy experienced HIV/HBV co-infected Chinese.
    Yang R; Gui X; Ke H; Xiong Y; Gao S
    J Viral Hepat; 2020 Feb; 27(2):127-134. PubMed ID: 31571343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of loss of hepatitis B surface antigen in HIV-infected patients.
    Psevdos G; Kim JH; Suh JS; Sharp VL
    World J Gastroenterol; 2010 Mar; 16(9):1093-6. PubMed ID: 20205279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.